Skip to main content

Cognitive Dysfunction clinical trials at University of California Health

3 research studies open to eligible people

Showing trials for
  • A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

    open to eligible people ages 55-80

    The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale (iADRS), a composite of cognition and function.

    at UCLA UCSD

  • Improving Cognition After Cancer

    open to eligible females ages 40 years and up

    This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

    at UCSD

  • Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment

    open to eligible people ages 55-90

    The purpose of this study is to see if stimulation of the brain can improve memory. The investigators will use a device called transcranial magnetic stimulation that can stimulate and activate a specific part of the brain that is important for memory. The study will enroll MCI subjects who will be randomly assigned to receive active or sham brain stimulation. 'Blinded' or 'sham-controlled' means that the subject will not know whether the treatment they receive is the active treatment or the non-active stimulation. In the 'sham' condition, the stimulator will turn on but will not actually be stimulating the target brain region.

    at UCLA

Our lead scientists for Cognitive Dysfunction research studies include .

Last updated: